Inspira Technologies receives $22.5 million purchase order for ART100 system, marking transition to revenue generation.

From GlobeNewswire: 2025-07-02 09:23:00

Inspira Technologies OXY B.H.N. Ltd. announced a $22.5 million purchase order for its FDA-cleared ART100 system, a major commercial milestone. The purchasing organization is based outside the U.S. and has strong ties to government and healthcare customers. The full payment is scheduled for 2025, with immediate implementation. This order marks the company’s transition to full-scale revenue generation and represents a fraction of its global market potential. CEO Dagi Ben-Noon views this order as a sign of market confidence and signals further global deployments. Inspira is in talks with other healthcare companies for potential agreements to support its commercial expansion strategy.



Read more at GlobeNewswire: Inspira Technologies Secures $22.5 Million Purchase Order,